Apyx Medical Corp. (APYX), an energy technology company specializing in electrosurgical equipment and medical devices, is drawing investor attention following strong preliminary revenue results for the fourth quarter and full year ended December 31, 2025.
The company's Helium Plasma Technology, marketed as Renuvion and J-Plasma, offers surgeons a unique ability to provide controlled heat to tissue to achieve their desired results. The company also leverages its deep expertise and decades of experience in unique waveforms through OEM agreements with other medical device manufacturers.
Subscribe to continue reading the article.
This article is part of our premium content offering.Subscribe with a RTTNews subscription.
Subscribe NowAlready subscribed? Sign in
For comments and feedback: editorial@rttnews.com